Roche winning on Perjeta supply, but running short of Boniva

Roche is getting production for its new breast cancer drug Perjeta back on track after some initial teething troubles, but now says it is facing shortages of osteoporosis therapy Boniva. Perjeta (pert…

---

Roche runs short on Boniva after overestimating generic erosion

Many companies have been caught off-guard by the extent to which generic competition has eaten away at their sales. Genentech says it managed to be caught by surprise, however, by a lack thereof; lead…

---

FDA: Injectable form of Genentech’s Boniva is in short supply

The FDA announced a shortage of Genentech's osteoporosis drug Boniva, saying forecasts failed to match demand.  -More- …

---

Missed forecast by Roche leads to Boniva shortage

While drug shortages often are tied to manufacturing interruptions, Roche's ($RHHBY) injectable form of its osteoporosis drug Boniva will be in limited supply for some weeks because the company didn't…

---